Performance Study of Newly Developed Ostomy Products
An Open-labelled, Randomised, Controlled, Crossover Investigation Evaluating Performance of a Newly Developed Ostomy Care Product Compared to Standard Care.
1 other identifier
interventional
122
1 country
1
Brief Summary
The purpose of the study is to evaluate leakage of a newly developed ostomy product compared to standard care in subjects with colostomies. Subjects will be asked to use each test product for 2 weeks - in total, the study period is 4 weeks and the hypothesis is to show that the newly developed ostomy product is significantly better to reduce leakage compared to standard care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Nov 2011
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 10, 2012
CompletedFirst Posted
Study publicly available on registry
January 20, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedResults Posted
Study results publicly available
January 9, 2014
CompletedJanuary 9, 2014
November 1, 2013
7 months
January 10, 2012
August 6, 2013
November 21, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Degree of Leakage. Each Baseplate Can Have a Score From 0-24 Points Were 0 is the Best Possible Outcome (No Leakage) and 24 Points is the Worst Possible Outcome (Full Plate Leakage)
Degree of leakage will be measured by a 25-point leakage scale (no leakage or up till 24 points of leakage), developed by Coloplast A/S. The subjects receive Petri dishes with pre-printed leakage scale on. The subject will place the Petri dish above the used baseplate and indicate where on the baseplate output appears. This is done by ticking of each area on the scale indicating the area of leakage.
14 days
Study Arms (2)
First Standard Care, then SenSura Mio
EXPERIMENTALSubjects first test Standard Care (Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima) and after cross-over SenSura Mio
First SenSura Mio, then Standard Care
EXPERIMENTALSubjects first test SenSura Mio and after cross-over Standard Care(Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima)
Interventions
Ostomy product - 1 piece closed bag
Ostomy product 1 piece closed bags. Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima.
Eligibility Criteria
You may qualify if:
- Have given written informed consent.
- Be at least 18 years of age and have full legal capacity.
- Have experienced leakage under the base plate at least once a week over the last two weeks.
- Be able to handle the bags themselves or with help from caregiver (e.g. spouse).
- Have a colostomy with a diameter between 20 and 45 mm.
- Have had their ostomy for at least three months.
- Currently use a 1-piece flat product with closed bag.
- Use minimum 1 product per day.
- Be suitable for participation in the investigation and for using a standard adhesive, flat base plate (evaluated by investigator).
You may not qualify if:
- Use irrigation during the study (flush the stoma with water).
- Currently receiving or have within the past 2 months received radio- and/or chemotherapy.
- Currently receiving or have within the past month received local or systemic steroid treatment in the peristomal area.
- Are pregnant or breastfeeding.
- Participating in other interventional clinical investigations or have previously participated in this investigation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Coloplast A/Slead
Study Sites (1)
Publicare
Cologne, Køln, Germany
Results Point of Contact
- Title
- Director of Clinical Trials
- Organization
- Coloplast A/S
Study Officials
- PRINCIPAL INVESTIGATOR
Wenche Sundberg, stoma nurse
Diakonhjemmet Sykhus, Oslo
- PRINCIPAL INVESTIGATOR
Merete Bjørke, Stoma Nurse
St. Olavs Hopsital
- PRINCIPAL INVESTIGATOR
Vigids Dagsland, Stoma Nurse
Haugesund Sykhus
- PRINCIPAL INVESTIGATOR
Randi Melum, Stoma Nurse
St. Olavs Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 10, 2012
First Posted
January 20, 2012
Study Start
November 1, 2011
Primary Completion
June 1, 2012
Study Completion
August 1, 2012
Last Updated
January 9, 2014
Results First Posted
January 9, 2014
Record last verified: 2013-11